The Value of Thermal Imaging for Knee Arthritis: A Single-Center Observational Study

안수민,천주향,홍석찬,이창근,유빈,오지선,김용길 연세대학교의과대학 2022 Yonsei medical journal Vol.63 No.2

Purpose: To compare (non-contact) thermal imaging with power Doppler (PD) for the evaluation of knee arthritis with joint effusion. Materials and Methods: We enrolled patients with knee arthritis who were scheduled to undergo an arthrocentesis of the kneefrom April to December 2020 at a single tertiary hospital. A thermography camera, FLIR ONE Pro, was used to obtain both thermographicand digital images on subjects. For each subject, thermography, ultrasonography, arthrocentesis, and blood tests wereconducted at the same study visit. Thermal imaging findings and clinical characteristics were compared by dividing the subjectsinto PD-positive and PD-negative groups on ultrasound. The receiver operating characteristic (ROC) curve analysis was used todetermine the accuracy of PD positivity. Results: A total of 30 knee arthritis patients were enrolled in this study. Knee temperature was significantly higher in PD-positivegroup compared to PD-negative group [maximum temperature (T max): 33.2°C vs. 30.5°C, p=0.025; minimum temperature (Tmin): 30.7°C vs. 27.0°C, p=0.015; average temperature (T ave): 32.1°C vs. 29.1°C, p=0.016]. Also, the joint fluid white blood cellcount was considerably higher in PD-positive group than in PD-negative group (24556 cells/mm3 vs. 7840 cells/mm3, p=0.010). The area under the ROC curve of the point measurement of T max, T min, and T ave ranged between 0.764 and 0.790. Conclusion: In this study, we found that high thermographic temperatures of the knee suggest a positive PD signal. Thus, thermographymight be used as an adjuvant tool of PD for non-invasive evaluation of knee arthritis.

처방경고 시스템 개발을 통한 취소처방 감소활동

곽경숙,천주향,홍지희,박소영,서지영,김성은,최현진,오경은,이관호,조정환,손창우,오명진,백영란,장상현,안희자,한지숙,윤현숙,박윤태,김선자 한국의료QA학회 2009 가을학술대회 Vol.2009 No.2

약품식별에 따른 오투약 방지 대책

박종민,우보은,천주향,조남춘,이용화,김기중,김영진,최인옥,한경애,박혜령,김영화,백수현 한국병원약사회 1994 병원약사회지 Vol.11 No.2

To try to find a solution to the problem of drug misadministration, we examined the preventive measures against it by making the shapes of drugs discriminative. And we suggest drugs should be checked out thoroughly by pharmacists and the shapes of them should be varied : giving drugs discrimination codes, varying the forms of colored tablets, film coated tablets, and capsules, preventing the letters on the surfaces of ampules from being wiped away, specifying expiring date of each ampule and giving ampules and vials multiformity need to be carried out. In addition to that, drug product information reference which contains shape, diameter, thickness and weight of each tablet should be made. We think more active studies regards to this matter should be proceeded.

전문약사 활동 실태에 대한 설문조사

최경숙,한옥연,민명숙,김승란,천주향,아영미,정지은,전광희,이주연,이영희 한국병원약사회 2022 병원약사회지 Vol.39 No.4

Background : To evaluate current status of certified pharmacy specialists’ activities to provide basic data for reorganization of certified pharmacy specialist’s area in the healthcare system and quality management. Methods : A questionnaire was developed to understand basic characteristics of certified pharmacy specialists. It consisted of four parts: basic information, information before specialty certification, activities after specialty certification, and satisfaction. Certified pharmacy specialists registered with the Korean Society of Health System Pharmacists were asked to participate in the survey. Surveys were conducted using an online system. Results : The response rate to the survey was 64.6%, with 51.2% of respondents having less than three years of experience in a specialty area. Of respondents, 63.5% had more than six years of hospital pharmacist experience before acquiring pharmacy specialist certification and 13.5% answered that they had acquired the Board of Pharmacy Specialist (BPS) certification before being certified as pharmacy specialists. Regarding reasons for acquiring pharmacy specialist certification, 68.7% answered ‘carrying out related clinical practice’ and 55.6% answered ‘self-development’. The rate of specialty-related practice was 44.0% in the year of acquisition, 42.0% in the first year, and 24.8% in the fifth year. Areas that showed a high rate of specialty- related practice until the fifth year were solid organ transplantation pharmacy (46.2%), critical care pharmacy (30.8%), oncology pharmacy (27.8%), and nutritional pharmacy (27.3%). Conclusion : In this study, we investigated activities and satisfaction of certified pharmacy specialists in the healthcare system. Results of this study could be used as fundamental data for establishing and facilitating a board-certified pharmacy-specialist system.

국내 의료기관에서 종양약료서비스 현황과 전문약사의 역할

박애령,문진영,서정애,고종희,이윤선,천주향,홍소연,이정현,김경임 한국병원약사회 2019 병원약사회지 Vol.36 No.4

Background : The Korean Society of Health-System Pharmacists conducted the first certified oncology pharmacist examination in 2010. Currently, there are more than 180 certified oncology pharmacists in Korea. The purpose of this study was to investigate the current status of oncology pharmacy service and the role of pharmacists and suggest future paths for certified oncology pharmacists in Korea. Methods : The survey was conducted on pharmacists working at oncology pharmacies, as well as doctors and nurses with oncology pharmacy services experience. Additionally, the focus group interview was conducted with certified oncology pharmacists to evaluate pharmacists’needs regarding improving the certified pharmacist system. Results : The survey was completed by 99 pharmacists, 33 doctors, and 65 nurses in 33 hospitals. Among the certified oncology pharmacists currently working, the percentage of those who work specifically in oncology pharmacies was 24.9%. Oncology pharmacy services comprise prescription review and intervention, medication history management, attending round and conference, education, quality improvement activity and research activity. When asked about the services provided by oncology pharmacists, the medical staff responded with prescription review and intervention, providing drug information, patient education, therapeutic drug monitoring consulting, adverse drug reaction monitoring, and medication history management. And the medical staff showed more than average satisfaction in each service field. In the focus group interview, similar findings were confirmed. Meanwhile, dissatisfactory factors included the combination of clinical and dispensing tasks, discontinuity of work due to department circulation, and difficulties caused by lack of manpower. Conclusions : The results show that certified oncology pharmacists were performing more advanced services than general pharmacists. Also, the medical staffs were fully aware of the oncology pharmacy services and satisfied with such services. However, the current certified pharmacist system has a limitation in that it lacks laws as well as a compensation system.

종양약료 전문약사 제도에 대한 국내외 현황 조사와 비교

박애령,문진영,서정애,고종희,이윤선,천주향,홍소연,강예슬,김경임 한국병원약사회 2019 병원약사회지 Vol.36 No.2

Background : Due to the increasing number of patients with cancer and the complexity of anti-cancer drug therapies, it has become important for the pharmacists to develop specialized knowledge and skills to provide enhanced pharmaceutical care for these patients. The concept of certified oncology pharmacist, however, is relatively new in Korea. The objective of this study was to review the certified oncology pharmacist systems in Korea and two advanced countries (the US and Japan) and provide a comparative analysis. Methods : The information related to certified oncology pharmacist system was obtained through the official websites of related organizations in each country. For obtaining the outcomes of pharmaceutical care services provided by certified oncology pharmacists, we explored the related domestic journals and PubMed database. Results : The Korean Society of Health-system Pharmacists (KSHP) conducted the first certified oncology pharmacist examination in 2010 in Korea. To take this examination, completion of a related education course (at least a total of 360 hours) administered by the KSHP is essential. In the United States, the Board Certified Oncology Pharmacist (BCOP) was approved by the board of pharmacy specialty in 1996. In Japan, there are four types of the specialized pharmacist in oncology depending on the organization; Board Certified Pharmacist in Oncology Pharmacy, Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS)-certified Senior Oncology Pharmacist, JSPHCS-certified Oncology Pharmacist, and Accredited Pharmacist of Ambulatory Cancer Chemotherapy. In the US and Japan, a specialist is required to possess rigorous practical experience as well as academic training. Conclusions : This study provides a deeper understanding of some of the practical issues that need to be addressed for improving the systems of certified oncology pharmacists in Korea.